Earnout Provisions In Pharmaceutical Transactions: Key Challenges And Strategies To Mitigate Risk - McDermott Will & Emery

Earnout Provisions In Pharmaceutical Transactions: Key Challenges And Strategies To Mitigate Risk

Overview


Global Head of Transactions, Harris Siskind and Aymen Mahmoud, co-head of the London Finance, Restructuring and Special Situations Group, were quoted in a report by FTI Consulting on Earnout Provisions in Pharmaceutical Transactions: Key Challenges and Strategies to Mitigate Risk.